Medicine
Gabapentin 400 mg capsule
Gabapentin 400 mg capsule is a generic prescription medicine for oral use, made by 48 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store gabapentin capsules at 20° to 25°C (68° to 77°F), excursions permitted…
Key facts
- Active ingredient (INN)
- Gabapentin
- Brand
- Sold under the generic name
- Strength
- 400 mg
- Dosage form
- Capsule
- Route
- Oral
- Packs
- 100 capsules, 500 capsules, 1000 capsules and 288 more
- Manufacturers
- Laurus LabsIndiaStrides PharmaIndiaAurobindo PharmaIndiaAscend LaboratoriesIndiaStallion LaboratoriesIndiaGranules IndiaIndiaMarksans PharmaIndiaAvet PharmaceuticalsIndiaCamber PharmaceuticalsIndiaCiplaIndia48 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store gabapentin capsules at 20° to 25°C (68° to 77°F), excursions permitted to 15° to 30°C (59° to 86°F) Repackaged/Relabeled by: Bryant Ranch Prepack, Inc.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N02BF01 Gabapentin
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 31 January 2008
- Identifiers
- RxCUI 310432, 310430, 310431 +2DailyMed set ID bc1316b6-1fc4-4990-95a8-489881772876, 14d61caa-17ce-4fa2-90fb-1470f3864be8, 934244c6-243d-436e-ad6c-f7bd28e45a86 +37NDC 71335-2700, 85534-0008, 55154-0579 +37Application ANDA078787, ANDA090858, ANDA206943 +15
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 48 labelers. The register lists 291 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 capsule in 1 bottle, plastic | 64380-731-01 | Strides PharmaIndia | 8 January 2025 |
| 500 capsule in 1 bottle, plastic | 64380-731-02 | Strides PharmaIndia | 8 January 2025 |
| 1000 capsule in 1 bottle, plastic | 64380-731-03 | Strides PharmaIndia | 4 April 2026 |
| 100 capsule in 1 bottle | 64380-869-06 | Strides PharmaIndia | 17 October 2018 |
| 500 capsule in 1 bottle | 64380-869-07 | Strides PharmaIndia | 17 October 2018 |
| 1000 capsule in 1 bottle | 64380-869-08 | Strides PharmaIndia | 1 June 2026 |
| 100 capsule in 1 bottle | 67877-224-01 | Ascend LaboratoriesIndia | 29 January 2011 |
| 500 capsule in 1 bottle | 67877-224-05 | Ascend LaboratoriesIndia | 29 January 2011 |
| 1000 capsule in 1 bottle | 67877-224-10 | Ascend LaboratoriesIndia | 29 January 2011 |
| 10 blister pack in 1 carton / 10 capsule in 1 blister pack | 67877-224-38 | Ascend LaboratoriesIndia | 27 March 2020 |
| 100 capsule in 1 bottle | 65862-200-01 | Aurobindo PharmaIndia | 31 January 2008 |
| 500 capsule in 1 bottle | 65862-200-05 | Aurobindo PharmaIndia | 31 January 2008 |
| 10 blister pack in 1 carton / 10 capsule in 1 blister pack | 65862-200-10 | Aurobindo PharmaIndia | 31 January 2008 |
| 270 capsule in 1 bottle | 65862-200-27 | Aurobindo PharmaIndia | 29 April 2021 |
| 90 capsule in 1 bottle | 65862-200-90 | Aurobindo PharmaIndia | 29 April 2021 |
| 100 capsule in 1 bottle | 23155-868-01 | Avet PharmaceuticalsIndia | 25 June 2023 |
| 500 capsule in 1 bottle | 23155-868-05 | Avet PharmaceuticalsIndia | 25 June 2023 |
| 100 capsule in 1 bottle | 31722-150-01 | Camber PharmaceuticalsIndia | 10 May 2021 |
| 500 capsule in 1 bottle | 31722-150-05 | Camber PharmaceuticalsIndia | 10 May 2021 |
| 100 capsule in 1 bottle | 69097-815-07 | CiplaIndia | 29 June 2016 |
| 500 capsule in 1 bottle | 69097-815-12 | CiplaIndia | 29 June 2016 |
| 100 capsule in 1 bottle | 70010-928-01 | Granules IndiaIndia | 1 September 2021 |
| 500 capsule in 1 bottle | 70010-928-05 | Granules IndiaIndia | 1 September 2021 |
| 1000 capsule in 1 bottle | 70010-928-10 | Granules IndiaIndia | 1 September 2021 |
| 100 capsule in 1 bottle | 42385-974-01 | Laurus LabsIndia | 13 May 2023 |
| 500 capsule in 1 bottle | 42385-974-05 | Laurus LabsIndia | 13 May 2023 |
| 1000 capsule in 1 bottle | 42385-974-11 | Laurus LabsIndia | 13 May 2023 |
| 30 capsule in 1 bottle | 42385-974-30 | Laurus LabsIndia | 13 May 2023 |
| 10 blister pack in 1 carton / 10 capsule in 1 blister pack | 42385-974-72 | Laurus LabsIndia | 13 May 2023 |
| 90 capsule in 1 bottle | 42385-974-90 | Laurus LabsIndia | 13 May 2023 |
| 30 capsule in 1 bottle | 25000-105-03 | Marksans PharmaIndia | 28 February 2011 |
| 500 capsule in 1 bottle | 25000-105-12 | Marksans PharmaIndia | 28 February 2011 |
| 1000 capsule in 1 bottle | 25000-105-14 | Marksans PharmaIndia | 16 September 2021 |
| 30 capsule in 1 bottle | 72737-007-01 | Stallion LaboratoriesIndia | 7 August 2025 |
| 100 capsule in 1 bottle | 72737-007-02 | Stallion LaboratoriesIndia | 7 August 2025 |
| 500 capsule in 1 bottle | 72737-007-03 | Stallion LaboratoriesIndia | 7 August 2025 |
| 1000 capsule in 1 bottle | 72737-007-04 | Stallion LaboratoriesIndia | 7 August 2025 |
| 50 capsule in 1 box, unit-dose | 62756-139-01 | Sun Pharmaceutical IndustriesIndia | 1 February 2022 |
| 100 capsule in 1 bottle | 62756-139-03 | Sun Pharmaceutical IndustriesIndia | 1 February 2022 |
| 100 capsule in 1 bottle | 49483-607-01 | Time Cap LaboratoriesIndia | 30 December 2015 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 30 December 1993 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Gabapentin 400 mg capsule.
Other strengths and forms of Gabapentin
Clinical summary
Gabapentin is an anti-epileptic agent indicated for management of postherpetic neuralgia in adults, among other approved uses. It is available as capsules, tablets and oral solution. MedsAcross supplies Gabapentin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about GabapentinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Neurontin prescribing information (Viatris Specialty) · U.S. National Library of Medicine, DailyMed
Need Gabapentin 400 mg capsule for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.